Association between Serum Lactate Dehydrogenase Level and 30-day Mortality in Patients with Intracranial Hemorrhage with Acute Leukemia in the Induction Phase: A Cohort Study

Abstract

Objectives This study aimed to identify the association between lactate dehydrogenase (LDH) levels and 30-day mortality in patients with intracranial hemorrhage (ICH) with acute leukemia during the induction phase.
Methods This cohort study included patients with acute leukemia with ICH during induction. We evaluated serum LDH levels upon admission. Multivariable Cox regression analyzed the LDH 30-day mortality association. Interaction and stratified analyses based on factors like age, sex, albumin, white blood cell count, hemoglobin level, and platelet count were conducted.
Results We selected 91 patients diagnosed with acute leukemia and ICH. The overall 30-day mortality rate was 61.5%, with 56 of the 91 patients succumbing. Among those with LDH levels ≥ 570 U/L, the mortality rate was 74.4% (32 out of 43), which was higher than the 50% mortality rate of the LDH < 570 U/L group (24 out of 48) (p = 0.017). In our multivariate regression models, the hazard ratios and their corresponding 95% confidence intervals for Log2 and twice the upper limit of normal LDH were 1.27 (1.01, 1.58) and 2.2 (1.05, 4.58), respectively. Interaction analysis revealed no significant interactive effect on the relationship between LDH levels and 30-day mortality.
Conclusions Serum LDH level was associated with 30-day mortality, especially in patients with LDH ≥ 570 U/L.

Keywords

lactate dehydrogenase / intracranial hemorrhage / acute leukemia

References

[[1]] Chen CY, Tai CH, Tsay W, Chen PY, Tien HF.Prediction of fatal intracranial hemorrhage in patients with acute myeloid leukemia. Ann Oncol 2009; 20(06) 1100-1104

[[2]] Chern JJ, Tsung AJ, Humphries W, Sawaya R, Lang FF.Clinical outcome of leukemia patients with intracranial hemorrhage. Clinical article. J Neurosurg 2011; 115(02) 268-272

[[3]] Ho G, Jonas BA, Li Q, Brunson A, Wun T, Keegan THM.Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia. Br J Haematol 2017; 177(05) 791-799

[[4]] Ho G, Wun T, Muffly L.et al.Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California. Cancer 2018; 124(09) 1938-1945

[[5]] Zhang J-Y, Li Y, Ma Y-S.et al.Clinical characteristics and prognostic factors in intracranial hemorrhage patients with hematological diseases. Ann Hematol 2022; 101(12) 2617-2625

[[6]] Sorror ML, Storer BE, Fathi AT.et al.Development and validation of a novel acute myeloid leukemia-composite model to estimate risks of mortality. JAMA Oncol 2017; 3(12) 1675-1682

[[7]] Petrelli F, Cabiddu M, Coinu A.et al.Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies. Acta Oncol 2015; 54(07) 961-970

[[8]] Augoff K, Hryniewicz-Jankowska A, Tabola R.Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. Cancer Lett 2015; 358(01) 1-7

[[9]] Choy DK, Wu PH, Tan D, Yeo TT, Chou N.Correlation of the long-term neurological outcomes with completeness of surgical evacuation in spontaneous supratentorial intracerebral haemorrhage: a retrospective study. Singapore Med J 2010; 51(04) 320-325

[[10]] Mendelow AD, Gregson BA, Fernandes HM.et al; STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365(9457) 387-397

[[11]] Proust F, Leveque S, Derrey S.et al.[Spontaneous supratentorial cerebral hemorrhage: role of surgical treatment]. Neurochirurgie 2007; 53(2-3 Pt 1): 58-65

[[12]] Qureshi AI, Mendelow AD, Hanley DF.Intracerebral haemorrhage. Lancet 2009; 373(9675) 1632-1644

[[13]] Sacco S, Marini C, Toni D, Olivieri L, Carolei A.Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke 2009; 40(02) 394-399

[[14]] Li H, Niu T, Huang J.et al.The characteristics and long-term outcomes of acute promyelocytic leukemia patients with early intracranial hemorrhage. Int J Hematol 2023; 117(04) 538-543

[[15]] Gurnari C, Breccia M, Di Giuliano F.et al.Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters. Br J Haematol 2021; 193(01) 129-132

[[16]] Döhner H, Estey E, Grimwade D.et al.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017; 129(04) 424-447

[[17]] Huang Y, Hu J, Lu T.et al.Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis. Cancer Manag Res 2019; 11: 4129-4142

[[18]] Hills RK, Castaigne S, Appelbaum FR.et al.Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials. Lancet Oncol 2014; 15(09) 986-996

[[19]] Dang H, Chen Y, Kamel-Reid S, Brandwein J, Chang H.CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia. Hum Pathol 2013; 44(10) 2038-2046

[[20]] Germing U, Hildebrandt B, Pfeilstöcker M.et al.Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). Leukemia 2005; 19(12) 2223-2231

RIGHTS & PERMISSIONS

2024 Global Medical Genetics